CTI BioPharma Corp. Stock Price - CTIC

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ and Amex.
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Cti Biopharma Corp. (MM) CTIC NASDAQ Common Stock US12648L6011
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.09 +2.43% 3.8 3.84 3.69 3.76 3.71 16:47:01
Bid Price Ask Price Spread Spread % News
3.61 3.9 0.29 7.44% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,724 832,716 $ 3.7961 $ 3.16M 327.76k 2.45 - 4.65
Last Trade Time Type Quantity Stock Price Currency
16:00:08 39 $3.80 USD
Industry Sector

Cti Biopharma Corp. (MM) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 164.15M 42.97M $ -52.01M -1.86 0.00 21.47M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 0.00 0.00% -14.6k 42.70%

more financials information »

Cti Biopharma Corp. (MM) News

Latest CTIC Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTIC Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week3.73.843.623.7226186k1M615k0.12.70%
1 Month3.393.842.483.295174k6M704k0.4112.09%
3 Months2.743.842.45143.184224k6M350k1.0638.69%
6 Months3.293.842.45143.179524k6M254k0.5115.50%
1 Year4.194.652.45143.32467k6M175k-0.39-9.31%
3 Years2352942.4514181.27887k4B86M-231.2-98.38%
5 Years1274252.4514232.64407k4B152M-123.2-97.01%

Cti Biopharma Corp. (MM) Description

Cell Therapeutics, Inc. develops, acquires and commercializes novel treatments for cancer. It researches, development, acquisition and in-licensing activities concentrate on identifying and developing new, less toxic and effective ways to treat cancer.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.